Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05728580

PCI in Beijing Friendship Hospital

Risk Factor for Percutaneous Coronary Intervention in the Beijing Friendship Hospital

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to discover the potential risk factors related percutaneous coronary intervention. It aims to stratify the risk of PCI patients and discover the prognostic value of these risk fators.

Detailed description

Coronary heart disease is the main cause of death worldwide. Ischemic heart disease is the most common cause of death. Percutaneous coronary intervention (PCI) is a very effective treatment for coronary heart disease, which can alleviate myocardial ischemia and reduce the mortality of patients with acute myocardial infarction. It is an important measure to treat coronary heart disease at present. However, the study found that the incidence of major adverse cardiac and cerebrovascular event (MACCE) after PCI was more than 10%, which could reach 20-30% in elderly patients. Therefore, the purpose of this study is to investigate the risk factors related to PCI and to intervene or change the treatment strategy as early as possible. Risk stratification was performed in these patients for improving the quality of life of patients, reducing medical costs, and improving the life expectancy of patients. Patients with PCI in Beijing friendship hospital are enrolled.The primary outcome is MACCE and all-cause mortality.

Conditions

Timeline

Start date
2017-12-31
Primary completion
2022-12-31
Completion
2027-12-31
First posted
2023-02-15
Last updated
2024-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05728580. Inclusion in this directory is not an endorsement.